Remove Invention Remove Patent Prosecution Remove Public Use Remove Trademark
article thumbnail

Request for Comments on USPTO Initiatives To Promote Generic Drug and Biosimilar Competition

LexBlog IP

Patent and Trademark Office (USPTO) recently published a request for comments addressing a variety of topics related to generic drug and biosimilar competition. How would eliminating terminal disclaimers, thus prohibiting patents that are obvious variations of each other, affect patent prosecution strategies and patent quality overall?